Literature DB >> 31066919

The American Cancer Society 2035 challenge goal on cancer mortality reduction.

Jiemin Ma1, Ahmedin Jemal2, Stacey A Fedewa1, Farhad Islami3, J Leonard Lichtenfeld4, Richard C Wender5, Kevin J Cullen6, Otis W Brawley7.   

Abstract

A summary evaluation of the 2015 American Cancer Society (ACS) challenge goal showed that overall US mortality from all cancers combined declined 26% over the period from 1990 to 2015. Recent research suggests that US cancer mortality can still be lowered considerably by applying known interventions broadly and equitably. The ACS Board of Directors, therefore, commissioned ACS researchers to determine challenge goals for reductions in cancer mortality by 2035. A statistical model was used to estimate the average annual percent decline in overall cancer death rates among the US general population and among college-educated Americans during the most recent period. Then, the average annual percent decline in the overall cancer death rates of college graduates was applied to the death rates in the general population to project future rates in the United States beginning in 2020. If overall cancer death rates from 2020 through 2035 nationally decline at the pace of those of college graduates, then death rates in 2035 in the United States will drop by 38.3% from the 2015 level and by 54.4% from the 1990 level. On the basis of these results, the ACS 2035 challenge goal was set as a 40% reduction from the 2015 level. Achieving this goal could lead to approximately 1.3 million fewer cancer deaths than would have occurred from 2020 through 2035 and 122,500 fewer cancer deaths in 2035 alone. The results also show that reducing the prevalence of risk factors and achieving optimal adherence to evidence-based screening guidelines by 2025 could lead to a 33.5% reduction in the overall cancer death rate by 2035, attaining 85% of the challenge goal.
© 2019 American Cancer Society.

Entities:  

Keywords:  breast cancer; cancer; colorectal cancer; lung cancer; mortality; prostate cancer; risk factor

Mesh:

Substances:

Year:  2019        PMID: 31066919     DOI: 10.3322/caac.21564

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  17 in total

1.  Long-term anti-inflammatory diet in relation to improved breast cancer prognosis: a prospective cohort study.

Authors:  Kang Wang; Jia-Zheng Sun; Qian-Xue Wu; Zhu-Yue Li; Da-Xue Li; Yong-Fu Xiong; Guo-Chao Zhong; Yang Shi; Qing Li; Jiali Zheng; Nitin Shivappa; James R Hébert; Theodoros Foukakis; Xiang Zhang; Hong-Yuan Li; Ting-Xiu Xiang; Guo-Sheng Ren
Journal:  NPJ Breast Cancer       Date:  2020-08-13

Review 2.  Trends in U.S. Population Health: The Central Role of Policies, Politics, and Profits.

Authors:  Jennifer Karas Montez; Mark D Hayward; Anna Zajacova
Journal:  J Health Soc Behav       Date:  2021-09

Review 3.  Disparities in Cardio-oncology: Effects On Outcomes and Opportunities for Improvement.

Authors:  Javaria Ahmad; Anjani Muthyala; Ashish Kumar; Sourbha S Dani; Sarju Ganatra
Journal:  Curr Cardiol Rep       Date:  2022-06-27       Impact factor: 3.955

4.  Breast cancer screening adherence rates and barriers of implementation in ethnic, cultural and religious minorities: A systematic review.

Authors:  Cristiana Sofia Ferreira; Joana Rodrigues; Stefanie Moreira; Filipa Ribeiro; Adhemar Longatto-Filho
Journal:  Mol Clin Oncol       Date:  2021-05-19

5.  Obesity and Cancer Risk in White and Black Adults: A Prospective Cohort Study.

Authors:  Justin C Brown; Shengping Yang; Emily F Mire; Xiaocheng Wu; Lucio Miele; Augusto Ochoa; Jovanny Zabaleta; Peter T Katzmarzyk
Journal:  Obesity (Silver Spring)       Date:  2021-06       Impact factor: 9.298

6.  Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study.

Authors:  Christopher J Cadham; Pianpian Cao; Jinani Jayasekera; Kathryn L Taylor; David T Levy; Jihyoun Jeon; Elena B Elkin; Kristie L Foley; Anne Joseph; Chung Yin Kong; Jennifer A Minnix; Nancy A Rigotti; Benjamin A Toll; Steven B Zeliadt; Rafael Meza; Jeanne Mandelblatt
Journal:  J Natl Cancer Inst       Date:  2021-08-02       Impact factor: 11.816

7.  Obesity and cancer death in white and black adults: A prospective cohort study.

Authors:  Justin C Brown; Shengping Yang; Emily F Mire; Xiaocheng Wu; Lucio Miele; Augusto Ochoa; Jovanny Zabaleta; Peter T Katzmarzyk
Journal:  Obesity (Silver Spring)       Date:  2021-10-24       Impact factor: 9.298

8.  Long-term anti-inflammatory diet in relation to improved breast cancer prognosis: a prospective cohort study.

Authors:  Kang Wang; Jia-Zheng Sun; Qian-Xue Wu; Zhu-Yue Li; Da-Xue Li; Yong-Fu Xiong; Guo-Chao Zhong; Yang Shi; Qing Li; Jiali Zheng; Nitin Shivappa; James R Hébert; Theodoros Foukakis; Xiang Zhang; Hong-Yuan Li; Ting-Xiu Xiang; Guo-Sheng Ren
Journal:  NPJ Breast Cancer       Date:  2020-08-13

9.  Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients.

Authors:  Jeffrey E Johnson; Paula D Strassle; Guilherme C de Oliveira; Chris B Agala; Philip Spanheimer; Kristalyn Gallagher; David Ollila; Hyman Muss; Stephanie Downs-Canner
Journal:  Breast Cancer Res Treat       Date:  2021-06-26       Impact factor: 4.624

10.  HAX1 enhances the survival and metastasis of non-small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway.

Authors:  Zhigang Liang; Yuan Zhong; Lifei Meng; Yi Chen; Yahui Liu; Aihua Wu; Xinjian Li; Mingsong Wang
Journal:  Thorac Cancer       Date:  2020-09-14       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.